Unnamed: 0,title,date,stock,sentiment
111967.0,Aurinia Presents Aurora Pivotal Trial Subgroup Analysis At The Eular 2020 E-Congress,2020-06-05 07:08:00-04:00,AUPH,neutral
111968.0,Aurinia Completes Submission Of New Drug Application To FDA For Voclosporin For The Treatment Of Lupus Nephritis,2020-05-26 06:06:00-04:00,AUPH,neutral
111969.0,"Aurinia Pharmaceuticals Q1 EPS $(0.150), Inline, Sales $30.000K Miss $50.000K Estimate",2020-05-14 16:06:00-04:00,AUPH,negative
111970.0,Aurinia Names Joe Miller as CFO,2020-04-27 06:06:00-04:00,AUPH,neutral
111971.0,Aurinia Announces AURORA Phase 3 Clinical Data For Voclosporin In Lupus Nephritis To Be Presented At National Kidney Foundation 2020 Spring Clinical Meetings,2020-03-18 06:12:00-04:00,AUPH,neutral
111972.0,"Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center In Rockville, Maryland",2020-03-17 06:05:00-04:00,AUPH,neutral
111973.0,Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the FDA for Voclosporin in the Treatment of Lupus Nephritis,2020-03-16 06:06:00-04:00,AUPH,neutral
111974.0,Aurinia Launches Its Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative,2020-03-12 07:15:00-04:00,AUPH,neutral
111975.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,AUPH,neutral
111976.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,AUPH,neutral
111977.0,"Cantor Fitzgerald Maintains Overweight on Aurinia Pharmaceuticals, Raises Price Target to $32",2020-03-06 06:30:00-05:00,AUPH,negative
111978.0,7 Stocks Moving In Thursday's After-Hours Session,2020-03-05 17:22:00-05:00,AUPH,neutral
111979.0,Aurinia Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.,2020-03-05 16:07:00-05:00,AUPH,neutral
111980.0,Aurinia Pharmaceuticals Q4 EPS $(0.78) Misses $(0.15) Estimate,2020-03-05 16:03:00-05:00,AUPH,negative
111981.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,AUPH,neutral
111982.0,Hearing Dealreporter Suggests Aurinia Pharmaceuticals Takeover Is Being Eyed By Other Larger Pharma Competitors; Unconfirmed,2020-01-02 09:52:00-05:00,AUPH,negative
111983.0,Stocks That Hit 52-Week Highs On Friday,2019-12-27 11:27:00-05:00,AUPH,neutral
111984.0,"The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping",2019-12-27 07:59:00-05:00,AUPH,neutral
111985.0,Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-12-26 13:17:00-05:00,AUPH,positive
111986.0,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict",2019-12-24 07:24:00-05:00,AUPH,negative
111987.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,AUPH,positive
111988.0,Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-12-17 12:54:00-05:00,AUPH,positive
111989.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-17 11:19:00-05:00,AUPH,neutral
111990.0,"H.C. Wainwright Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $32",2019-12-16 07:56:00-05:00,AUPH,neutral
111991.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,AUPH,positive
111992.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,AUPH,neutral
111993.0,"Amarin, Aurinia Shares Appear Unaffected Following Recent Motley Foot Article From George Budwell '2 Top Biotech Buyout Candidates'",2019-12-11 10:23:00-05:00,AUPH,positive
111994.0,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",2019-12-11 07:21:00-05:00,AUPH,negative
111995.0,66 Biggest Movers From Yesterday,2019-12-11 04:52:00-05:00,AUPH,neutral
111996.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-10 14:27:00-05:00,AUPH,neutral
111997.0,Aurinia Pharmaceuticals shares are trading higher on continued upward momentum after the company announced URORA Phase 3 trial results of Voclosporin met primary endpoints  and showed statistical significance in all pre-specified hierarchical secondary endpoints.,2019-12-10 10:23:00-05:00,AUPH,positive
111998.0,41 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-10 08:10:00-05:00,AUPH,neutral
111999.0,Aurinia Prices 11.1M Share Public Offering of Common Shares @$15/Share,2019-12-09 21:05:00-05:00,AUPH,positive
112000.0,"Aurinia Pharmaceuticals Commences A Registered Underwritten Public Offering Of $150,000,000 Of Its Common Shares",2019-12-09 06:22:00-05:00,AUPH,positive
112001.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",2019-12-07 08:35:00-05:00,AUPH,positive
112002.0,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",2019-12-06 07:39:00-05:00,AUPH,positive
112003.0,30 Stocks Moving in Friday's Pre-Market Session,2019-12-06 07:23:00-05:00,AUPH,neutral
112004.0,75 Biggest Movers From Yesterday,2019-12-06 05:36:00-05:00,AUPH,neutral
112005.0,Mid-Afternoon Market Update: U.S. Stocks Turn Positive; At Home Group Shares Fall,2019-12-05 14:40:00-05:00,AUPH,positive
112006.0,Aurinia Pharmaceuticals Call Buyers Hit The Jackpot With Well-Timed Option Trades,2019-12-05 12:36:00-05:00,AUPH,neutral
112007.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-12-05 12:07:00-05:00,AUPH,neutral
112008.0,Mid-Day Market Update: Express Jumps After Strong Q3 Results; Sage Therapeutics Shares Plunge,2019-12-05 12:02:00-05:00,AUPH,positive
112009.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-05 10:16:00-05:00,AUPH,neutral
112010.0,Mid-Morning Market Update: Markets Open Lower; Dollar General Earnings Top Expectations,2019-12-05 10:13:00-05:00,AUPH,negative
112011.0,Aurinia's Stock More Than Doubles On Results From Pivotal Trial Of Voclosporin In Lupus Nephritis,2019-12-05 09:20:00-05:00,AUPH,neutral
112012.0,17 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-12-05 07:55:00-05:00,AUPH,neutral
112013.0,Aurinia Pharmaceuticals shares are trading higher after the company announced URORA Phase 3 trial results of Voclosporin in Lupus Nephritis met primary endpoints and showed statistical significance in all pre-specified hierarchical secondary endpoints.,2019-12-05 07:39:00-05:00,AUPH,positive
112014.0,40 Stocks Moving in Thursday's Pre-Market Session,2019-12-05 07:30:00-05:00,AUPH,neutral
112015.0,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",2019-12-05 07:14:00-05:00,AUPH,positive
112016.0,"A Peek Into The Markets: US Stock Futures Climb Ahead Of International Trade, Factory Orders Data",2019-12-05 06:29:00-05:00,AUPH,neutral
112017.0,Aurinia Pharmaceuticals shares are trading higher after the company announced URORA Phase 3 trial results of Voclosporin in Lupus Nephritis met primary endpoints and showed statistical significance in all pre-specified hierarchical secondary endpoints.,2019-12-04 16:42:00-05:00,AUPH,positive
112018.0,"Aurinia Pharma Shares Resume Trade, Up 172%",2019-12-04 16:36:00-05:00,AUPH,positive
112019.0,Aurinia Shares To Resume Trade At 4:35 p.m. EST,2019-12-04 16:12:00-05:00,AUPH,positive
112020.0,Aurinia URORA Phase 3 Trial Results Of Voclosporin In Lupus Nephritis Met Primary Endpoints And Shows Statistical Significance In All Pre-Specified Hierarchical Secondary Endpoints,2019-12-04 16:12:00-05:00,AUPH,positive
112021.0,Aurinia Pharma Shares Halted News Pending,2019-12-04 16:03:00-05:00,AUPH,positive
112022.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-04 10:30:00-05:00,AUPH,neutral
112023.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",2019-12-03 07:59:00-05:00,AUPH,neutral
112024.0,Stocks That Hit 52-Week Highs On Monday,2019-12-02 10:15:00-05:00,AUPH,neutral
112025.0,52 Biggest Movers From Friday,2019-12-02 04:44:00-05:00,AUPH,neutral
112026.0,60 Biggest Movers From Yesterday,2019-11-27 05:03:00-05:00,AUPH,neutral
112027.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-11-26 12:09:00-05:00,AUPH,neutral
112028.0,Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-11-26 10:14:00-05:00,AUPH,positive
112029.0,Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-11-19 14:39:00-05:00,AUPH,positive
112030.0,72 Biggest Movers From Yesterday,2019-11-19 04:39:00-05:00,AUPH,neutral
112031.0,Aurinia Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-11-18 11:44:00-05:00,AUPH,positive
112032.0,"Aurinia Pharmaceuticals Q3 EPS $(0.21) Misses $(0.15) Estimate, Sales $230K Beat $50K Estimate",2019-11-14 16:15:00-05:00,AUPH,negative
112033.0,Aurinia Pharmaceuticals Option Alert: Dec 20 $10 Calls at the Ask: 3700 @ $0.7 vs 9474 OI; Earnings 11/14 After Close Ref=$5.08,2019-11-11 14:06:00-05:00,AUPH,positive
112034.0,Aurinia Announces Initiation Of Patient Dosing In Phase 2/3 AUDREY Clinical Trial For Dry Eye Syndrome,2019-10-31 08:20:00-04:00,AUPH,neutral
112035.0,54 Biggest Movers From Yesterday,2019-10-17 05:52:00-04:00,AUPH,neutral
112036.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-10-16 12:35:00-04:00,AUPH,neutral
112037.0,Aurinia Pharmaceuticals Option Alert: Jan 17 $12 Calls at the Ask: 500 @ $0.801 vs 1876 OI; Earnings 11/7 After Close [est] Ref=$5.07,2019-10-16 10:16:00-04:00,AUPH,positive
112038.0,63 Biggest Movers From Yesterday,2019-10-16 04:04:00-04:00,AUPH,neutral
112039.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-10-15 12:48:00-04:00,AUPH,neutral
112040.0,"Aurinia Pharmaceuticals shares are trading higher in sympathy with the overall market after multiple companies reported earnings that topped expectations, bringing the whole market higher on positive sentiment.",2019-10-15 11:50:00-04:00,AUPH,positive
112041.0,Aurinia Pharmaceuticals Option Alert: Dec 20 $5 Calls Sweep (25) near the Ask: 720 @ $1.8 vs 592 OI; Earnings 11/7 After Close [est] Ref=$4.34,2019-10-11 09:37:00-04:00,AUPH,positive
112042.0,55 Biggest Movers From Yesterday,2019-10-11 06:28:00-04:00,AUPH,neutral
112043.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-10 11:08:00-04:00,AUPH,negative
112044.0,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO",2019-10-10 07:31:00-04:00,AUPH,neutral
112045.0,"The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug",2019-10-09 07:58:00-04:00,AUPH,negative
112046.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-08 12:02:00-04:00,AUPH,negative
112047.0,"The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration",2019-10-08 07:11:00-04:00,AUPH,negative
112048.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-03 13:03:00-04:00,AUPH,negative
112049.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-02 10:55:00-04:00,AUPH,negative
112050.0,22 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-16 08:29:00-04:00,AUPH,neutral
112051.0,80 Biggest Movers From Yesterday,2019-09-11 05:11:00-04:00,AUPH,neutral
112052.0,"Benzinga's Top Upgrades, Downgrades For September 10, 2019",2019-09-10 09:38:00-04:00,AUPH,positive
112053.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-10 09:02:00-04:00,AUPH,neutral
112054.0,"Oppenheimer Initiates Coverage On Aurinia Pharmaceuticals with Outperform Rating, Announces $14 Price Target",2019-09-10 06:38:00-04:00,AUPH,neutral
112055.0,"Aurinia Pharmaceuticals Q2 EPS $(0.17) Up From $(0.19) YoY, Sales $29K, Same YoY",2019-08-06 16:26:00-04:00,AUPH,neutral
112056.0,ILJIN Chairman Issues Letter To Aurinia Shareholders Seeking To Replace Three Incumbent Directors,2019-06-21 08:00:00-04:00,AUPH,neutral
112057.0,"Aurinia Pharma Reports ISS, Glass Lewis Have Recommended Shareholders Vote On YELLOW Proxy Card For All Co. Nominees",2019-06-19 06:31:00-04:00,AUPH,positive
112058.0,"ILJIN SNT Sends Letter To Aurinia Pharmaceuticals Shareholders, Urges Shareholders To Vote For Board Changes",2019-06-10 14:59:00-04:00,AUPH,neutral
112059.0,Aurinia Pharma Sends Letter To Shareholders,2019-06-07 08:02:00-04:00,AUPH,neutral
112060.0,"Aurinia Pharmaceuticals Shareholder, ILJIN SNT, Issues Letter To Shareholders Seeking Support For Board Nominees",2019-06-03 15:10:00-04:00,AUPH,positive
112061.0,"Aurinia Pharmaceuticals Inc - Common Shares Q1 EPS $(0.14), Inline, Sales $30K Miss $40K Estimate",2019-05-14 16:02:00-04:00,AUPH,positive
112062.0,Aurinia Pharmaceuticals Option Alert: May 17 $2.5 Calls Sweep (2) near the Ask: 950 @ $4.0 vs 0 OI; Earnings 5/9 After Close [est] Ref=$6.43,2019-04-09 14:31:00-04:00,AUPH,positive
112063.0,Aurinia Pharmaceuticals Option Alert: Apr 18 $5 Calls at the Ask: 500 @ $1.9 vs 2678 OI; Earnings 5/9 After Close [est] Ref=$6.9,2019-03-20 11:52:00-04:00,AUPH,positive
112064.0,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",2019-03-20 07:46:00-04:00,AUPH,negative
112065.0,Aurinia Pharmaceuticals Inc Q4 EPS $(0.17) Misses $(0.14) Estimate,2019-03-19 16:02:00-04:00,AUPH,negative
112066.0,72 Biggest Movers From Yesterday,2019-02-26 05:31:00-05:00,AUPH,neutral
112067.0,Aurinia Pharmaceuticals shares are trading higher after the company received a notice of allowance from the US Patent and Trademark Office for claims directed to its novel voclosporin dosing protocol.,2019-02-25 13:24:00-05:00,AUPH,positive
112068.0,Aurinia Receives Notice of Allowance from the US Patent and Trademark Office for Claims Directed to Its Novel Voclosporin Dosing Protocol for Lupus Nephritis,2019-02-25 07:00:00-05:00,AUPH,positive
112069.0,55 Biggest Movers From Yesterday,2019-01-23 05:19:00-05:00,AUPH,neutral
112070.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-01-22 12:21:00-05:00,AUPH,neutral
112071.0,Aurinia's Dry Eye Syndrome Drug Produces Mixed Results In Mid-Stage Trial,2019-01-22 09:09:00-05:00,AUPH,neutral
112072.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-22 08:04:00-05:00,AUPH,neutral
112073.0,"UPDATE: Aurinia Reports Primary Endpoint Of Drop Discomfort At 1-minute On Day 1 Showed No Statistical Difference Between Vos And Restasis, As Both Exhibited Low Drop Discomfort Scores",2019-01-22 07:07:00-05:00,AUPH,negative
112074.0,Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis In Phase 2 Head-to-Head Study For Treatment Of Dry Eye Syndrome,2019-01-22 07:05:00-05:00,AUPH,positive
112075.0,"Aurinia to Hold Conference Call and Webcast at 8:00am ET on Tuesday, January 22, 2019 to Discuss Results of Phase 2 Head-to-Head Study of Voclosporin Ophthalmic Solution vs Restasis for the Treatment of Dry Eye Syndrome",2019-01-21 17:37:00-05:00,AUPH,positive
112076.0,"Jim Cramer Gives His Opinion On Barrick Gold, Exxon, Nike And More",2019-01-16 07:49:00-05:00,AUPH,neutral
112077.0,"Stocks Which Set New 52-Week High Yesterday, Thurs., Jan. 10, 2019",2019-01-11 13:04:00-05:00,AUPH,neutral
112078.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Jan. 7, 2019",2019-01-08 11:04:00-05:00,AUPH,neutral
112079.0,22 Stocks Moving In Monday's Pre-Market Session,2018-12-31 08:03:00-05:00,AUPH,neutral
112080.0,"Aurinia Pharmaceuticals Inc - Common Shares Q3 EPS $(0.21) Misses $(0.14) Estimate, Sales $375K Beat $40K Estimate",2018-11-08 16:53:00-05:00,AUPH,positive
112081.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,AUPH,positive
112082.0,"Aurinia Completes Enrollment Of AURORA, Its Phase 3 Clinical Trial For The Treatment Of Lupus Nephritis; Target Enrollment Has Been Exceeded And Completed Ahead Of Schedule",2018-09-25 16:02:00-04:00,AUPH,neutral
112083.0,"Aurinia Pharmaceuticals Inc - Common Shares Q2 EPS $(0.19) Misses $(0.14) Estimate, Sales $29K Miss $40K Estimate",2018-08-09 16:39:00-04:00,AUPH,negative
112084.0,"Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial",2018-07-12 08:37:00-04:00,AUPH,neutral
112085.0,Aurinia Initiates Phase 2 Clinical Trial For Voclosporin Ophthalmic Solution For Treatment Of Dry Eye Syndrome,2018-07-11 16:02:00-04:00,AUPH,positive
112086.0,"Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again",2018-05-11 08:21:00-04:00,AUPH,negative
112087.0,"Aurinia Pharmaceuticals Q1 EPS $(0.18) Misses $(0.15) Estimate, Sales $30K Miss $50K Estimate",2018-05-10 17:14:00-04:00,AUPH,negative
112088.0,48 Biggest Movers From Friday,2018-03-19 06:01:00-04:00,AUPH,neutral
112089.0,36 Stocks Moving In Friday's Mid-Day Session,2018-03-16 12:35:00-04:00,AUPH,neutral
112090.0,28 Stocks Moving In Friday's Pre-Market Session,2018-03-16 08:04:00-04:00,AUPH,neutral
112091.0,"Aurinia Pharma Reports Q4 EPS $(0.04) vs $(0.14) Est., Sales $31K vs $40K Est.",2018-03-15 16:05:00-04:00,AUPH,neutral
112092.0,"RBC Capital Initiates Coverage On Aurinia Pharmaceuticals with Outperform Rating, Announces $9.00 Price Target",2018-02-08 09:14:00-05:00,AUPH,neutral
112093.0,Aurinia Pharma Shares Spike Higher Amid Speculation Co. Considering Sale,2018-01-17 14:54:00-05:00,AUPH,positive
112094.0,Aurinia Pharma F-10 Filing Shows Registration For $250M Mixed Securities Shelf Offering,2018-01-04 16:35:00-05:00,AUPH,positive
112095.0,14 Stocks Moving In Tuesday's After-Hours Session,2017-11-14 17:11:00-05:00,AUPH,neutral
112096.0,"Aurinia Reports Q3 EPS $(0.16) vs. $(0.15) Est., Sales $29K vs. $31K In Same Qtr. Last Year",2017-11-14 16:01:00-05:00,AUPH,neutral
112097.0,"Lightning Round: Jim Cramer Gives His Opinion On Aurinia, GameStop, And More",2017-11-06 10:29:00-05:00,AUPH,neutral
112098.0,"Robert Duggan Reports 5.9% Stake in Aurinia Pharma as of Oct 19, 2017 vs 7.2% as of Apr 21, 2017 -13D/A",2017-10-23 17:55:00-04:00,AUPH,neutral
112099.0,Benzinga's Option Alert Recap From October 19,2017-10-19 16:41:00-04:00,AUPH,positive
112100.0,Aurinia Pharma Option Alert: Apr 20 $5 Puts Sweep (2) at the Ask: 630 @ $0.551 vs 251 OI; Ref=$6.45,2017-10-19 12:15:00-04:00,AUPH,positive
112101.0,"Seaport Global Initiates Coverage On Aurinia Pharmaceuticals Inc - Common Shares with Buy Rating, Announces $10.00 Price Target",2017-10-06 09:57:00-04:00,AUPH,positive
112102.0,"Benzinga's Top Upgrades, Downgrades For October 6, 2017",2017-10-06 09:24:00-04:00,AUPH,positive
112103.0,"Cantor Fitzgerald Global Healthcare Conference Continues Today, Presenters Include:  Innoviva, Puma Biotech, Magellan Health, TherapeuticsMD, Zoetis, Aurinia Pharma and Celgene",2017-09-26 08:36:00-04:00,AUPH,neutral
112104.0,Don't Judge A Note By Its Title: Aurinia Falls On Misinterpreted 'Downgrade',2017-09-13 15:25:00-04:00,AUPH,negative
112105.0,Aurinia Pharma Shares Down 2.35% Following Earlier Rating Change By Canaccord's Neil Maruoka; Maruoka Tells Benzinga Change Was Due To Speculative Nature Of Investment;  Says 'It was technically listed as a downgrade; although I don't view it this way',2017-09-13 14:11:00-04:00,AUPH,positive
112106.0,Canaccord Genuity Downgrades Aurinia Pharmaceuticals Inc - Common Shares to Speculative Buy,2017-09-13 06:56:00-04:00,AUPH,positive
112107.0,Aurinia Pharma Spikes to High of $6.45 on Volume,2017-08-31 11:20:00-04:00,AUPH,neutral
112108.0,"Aurinia Pharma Reports Q2 GAAP EPS $(0.03), Adj. Net Loss $9.9M, Sales $329K vs $60K Est.",2017-08-10 16:32:00-04:00,AUPH,negative
112109.0,"Companies Holding Shareholder Meetings Today Include: Adaptimmune Therapeutics, Aurinia Pharma, BlackBerry, Box, FleetCor, and IAC",2017-06-21 08:58:00-04:00,AUPH,neutral
112110.0,Ongoing Aurinia Pharmaceuticals Study Results Boost Shares Higher,2017-06-16 09:13:00-04:00,AUPH,positive
112111.0,22 Stocks Moving In Friday's Pre-Market Session,2017-06-16 08:28:00-04:00,AUPH,neutral
112112.0,"Aurinia Pharmaceuticals Says No Unexpected Safety Signals, Adverse Events Were Observed; Voclosporin Was Generally Well-tolerated; Voclosporin Treated Groups Showed Statistically Significant Improvement Over Control Group In Speed, Rates Of Complete, Part",2017-06-16 08:05:00-04:00,AUPH,positive
112113.0,Aurinia Pharma Announces Voclosporin Remission Data from the Phase IIb AURA-LV Study Highlighted at EULAR 2017,2017-06-16 08:02:00-04:00,AUPH,neutral
112114.0,"Aurinia Pharma Reports Presentation of Added Data from Phase IIB AURA-LV Study, Showed Stable Renal Function and Blood Pressure without Electrolyte Complications Through 48 Weeks",2017-06-05 11:28:00-04:00,AUPH,neutral
112115.0,Aurinia Pharma Offers Added Data from Phase IIb Aura-Lv Study: Demonstrating Stable Renal Function and Blood Pressure without Electrolyte Complications Through 48 Weeks,2017-06-05 08:16:00-04:00,AUPH,neutral
112116.0,Aurinia Shares Higher After Hours; Co. To Participate In 2 Late Breaking Oral Presentations At Upcoming Scientific Conferences,2017-05-30 16:21:00-04:00,AUPH,positive
112117.0,Aurinia Doses 1st Patient In AURORA Phase 3 Clinical Trial Of Voclosporin,2017-05-17 16:02:00-04:00,AUPH,neutral
112118.0,Aurinia Reports Q1 EPS $(0.13) vs $(0.12) Est.,2017-05-15 08:04:00-04:00,AUPH,neutral
112119.0,"Aurinia Pharma Shares Spiked Into Positive Territory Midday Wed., Up ~3%, on No News; Co. Has Historically Reported Q1 Results This Week, However Co. Spokesperson Has Confirmed No Definitive Date Set for Q1 Earnings",2017-05-10 15:34:00-04:00,AUPH,positive
112120.0,Aurinia Pharma Pops to High of $7.41 on Volume,2017-05-10 14:57:00-04:00,AUPH,neutral
112121.0,Aurinia Pharma Shares Sell off to Low of $7.15 on Volume,2017-05-02 11:58:00-04:00,AUPH,neutral
112122.0,Robert Duggan Reports 7.2% Stake in Aurinia Pharma in 13D,2017-05-01 17:33:00-04:00,AUPH,neutral
112123.0,Watch These 8 Huge Call Purchases In Friday Trade,2017-04-28 04:15:00-04:00,AUPH,positive
112124.0,Benzinga's Option Alert Recap From April 27,2017-04-27 17:01:00-04:00,AUPH,positive
112125.0,Option Alert: Aurinia Pharm Jul 10.0 Calls Sweep: 500 @  ASK  $0.45: 520 traded vs 4596 OI:  Earnings 5/10 After Close [est]  $7.22 Ref,2017-04-27 12:19:00-04:00,AUPH,positive
112126.0,15 Biggest Mid-Day Gainers For Friday,2017-04-21 12:41:00-04:00,AUPH,neutral
112127.0,"Aurinia Pharma's Phase 2b Data Lifts Stock, Suggests Big Potential",2017-04-21 09:16:00-04:00,AUPH,neutral
112128.0,25 Stocks Moving In Friday's Pre-Market Session,2017-04-21 08:31:00-04:00,AUPH,neutral
112129.0,Aurinia Pharma +8.5% Premarket @$7.60; Co Announced Positive Voclosporin Data on Thursday,2017-04-21 06:18:00-04:00,AUPH,positive
112130.0,UPDATE: Aurinia Announces Data from AURA-LV Study Showed 100% of Patients In Complete Remission at Week 24 Stay in Complete Remission at Week 48 While on Low-Dose Voclosporin,2017-04-20 17:02:00-04:00,AUPH,neutral
112131.0,Aurinia Reports Added 48-Week Data from AURA-LV Study at NKF Meetings,2017-04-20 17:01:00-04:00,AUPH,neutral
112132.0,Watch These 10 Huge Call Purchases In Thursday Trade,2017-04-20 04:06:00-04:00,AUPH,positive
112133.0,Option Alert: Aurinia Apr 7.5 Calls Sweep: 500 @  ASK  $0.15: 1156 traded vs 9995 OI:  Earnings 5/10 After Close [est]  $6.90 Ref,2017-04-19 15:04:00-04:00,AUPH,positive
112134.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-04-18 08:35:00-04:00,AUPH,neutral
112135.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-04-11 09:27:00-04:00,AUPH,neutral
112136.0,Aurinia Pharma Shares Could Be A 2-Bagger From Here,2017-04-11 08:14:00-04:00,AUPH,positive
112137.0,"Cantor Fitzgerald Initiates Coverage On Aurinia Pharmaceuticals Inc - Common Shares at Overweight, Announces price target $14.00",2017-04-10 16:12:00-04:00,AUPH,negative
112138.0,12 Biggest Mid-Day Gainers For Friday,2017-04-07 12:21:00-04:00,AUPH,neutral
112139.0,18 Stocks Moving In Friday's Pre-Market Session,2017-04-07 08:39:00-04:00,AUPH,neutral
112140.0,Aurinia Pharmaceuticals +13% Premarket @ $7.45,2017-04-07 06:56:00-04:00,AUPH,neutral
112141.0,"Aurinia Reports Development Plans for Voclosporin in Europe, Japan",2017-04-06 17:12:00-04:00,AUPH,neutral
112142.0,Adam Feuerstein Sees Major Price Manipulation In Small-Cap Pharma Stocks,2017-04-05 09:53:00-04:00,AUPH,negative
112143.0,"Feuerstein Says He Likes Aurinia Pharma, Think's Mgmt is Doing a Good Job",2017-04-05 08:57:00-04:00,AUPH,positive
112144.0,Adam Feuerstein Tweets: Re: $AUPH — spox @ceels66 pushes back on kidney biopsy bear thesis outlined in today's Seeking Alpha story. Statement below:,2017-03-28 16:27:00-04:00,AUPH,neutral
112145.0,15 Biggest Mid-Day Losers For Tuesday,2017-03-28 13:00:00-04:00,AUPH,negative
112146.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-03-28 08:28:00-04:00,AUPH,neutral
112147.0,20 Stocks Moving In Monday's Pre-Market Session,2017-03-27 08:20:00-04:00,AUPH,neutral
112148.0,"Aurinia Pharmaceuticals Announces Announces 48-Week Results from ""Aurinia Early Urinary Protein Reduction Predicts Response Study"" Of Voclosporin for Treatment Of Lupus Nephritis Achieved Primary Objective",2017-03-27 06:17:00-04:00,AUPH,neutral
112149.0,"Aurinia Pharma Says 48 Week Study Achieved Primary Objective, Says Was Well Tolerated",2017-03-27 06:17:00-04:00,AUPH,positive
112150.0,Watch These 5 Huge Put Purchases In Monday Trade,2017-03-27 05:29:00-04:00,AUPH,positive
112151.0,Benzinga's Option Alert Recap From March 24,2017-03-24 16:15:00-04:00,AUPH,positive
112152.0,Option Alert: Aurinia Pharma Apr 5.0 Puts Sweep: 500 @  ASK  $0.10: 595 traded vs 1586 OI:  Earnings 5/10 After Close (est)  $8.18 Ref,2017-03-24 12:20:00-04:00,AUPH,positive
112153.0,15 Biggest Mid-Day Gainers For Wednesday,2017-03-22 12:40:00-04:00,AUPH,neutral
112154.0,18 Stocks Moving In Wednesday's Pre-Market Session,2017-03-22 08:19:00-04:00,AUPH,neutral
112155.0,12 Biggest Mid-Day Gainers For Monday,2017-03-20 12:38:00-04:00,AUPH,neutral
112156.0,Don't Let Offerings Blindside Your Thesis,2017-03-19 13:51:00-04:00,AUPH,neutral
112157.0,6 Tweets Tell The Aurinia Pharma Story,2017-03-14 15:48:00-04:00,AUPH,neutral
112158.0,18 Biggest Mid-Day Losers For Tuesday,2017-03-14 13:12:00-04:00,AUPH,negative
112159.0,Mid-Morning Market Update: Markets Open Lower; DSW Earnings Beat Views,2017-03-14 10:04:00-04:00,AUPH,negative
112160.0,22 Stocks Moving In Tuesday's Pre-Market Session,2017-03-14 08:26:00-04:00,AUPH,neutral
112161.0,Aurinia Pharma Prices Offering of 22.3M Shares at $6.75/Share,2017-03-14 08:02:00-04:00,AUPH,positive
112162.0,Aurinia Pharmaceuticals -17.4% Premarket @$8.71; Co Announced Stock Offering on Monday,2017-03-14 06:43:00-04:00,AUPH,neutral
112163.0,Aurinia Pharmaceutical Down 18.69% After Hours,2017-03-13 17:02:00-04:00,AUPH,neutral
112164.0,"Adam Feuerstein Tweets: Yes. Long-term, fundamental investors buying $AUPH deal aren't paying a premium for your momentum-fueled trading.",2017-03-13 16:47:00-04:00,AUPH,positive
112165.0,"Adam Feuerstein Tweets: $AUPH — hearing 15M shares offered at $6.25 to $6.75. Demand strong, could raise price.",2017-03-13 16:17:00-04:00,AUPH,positive
112166.0,"@adamfeuerstein Tweet $AUPH looking to raise $100M, source tells me.",2017-03-13 16:09:00-04:00,AUPH,neutral
112167.0,"Adam Feuerstein Tweets: $AUPH looking to raise $100M, source tells me.",2017-03-13 16:09:00-04:00,AUPH,neutral
112168.0,Aurinia Reports Public Offering of Common Shares,2017-03-13 16:01:00-04:00,AUPH,positive
112169.0,"Several Biotherapeutics Stocks Outperforming: Cerulean Pharma Up 44%, Adaptimmune 16%, Aurinia 15%, Versatem 14.5%, Heat Biologics 14%, Calithera 14%",2017-03-13 10:54:00-04:00,AUPH,neutral
112170.0,Aurinia Reports Q4 EPS $(0.21) vs. $(0.13) YoY,2017-03-09 08:31:00-05:00,AUPH,neutral
112171.0,15 Biggest Mid-Day Gainers For Monday,2017-03-06 12:56:00-05:00,AUPH,neutral
112172.0,"Cowen Annual Healthcare Conference Begins Today; Presenters Include Insulet, PARAXEL, Zoetis, Alexion, Bristol-Myers, Acadia, Alnylam, Axovant, Ardelyx, Aurinia Pharma, And Puma Biotech",2017-03-06 08:39:00-05:00,AUPH,neutral
112173.0,20 Stocks Moving In Monday's Pre-Market Session,2017-03-06 08:10:00-05:00,AUPH,neutral
112174.0,15 Biggest Mid-Day Gainers For Friday,2017-03-03 12:46:00-05:00,AUPH,neutral
112175.0,22 Stocks Moving In Friday's Pre-Market Session,2017-03-03 08:28:00-05:00,AUPH,neutral
112176.0,Mid-Afternoon Market Update: Crude Oil Down 2%; Ameresco Shares Spike Higher,2017-03-02 14:30:00-05:00,AUPH,negative
112177.0,25 Biggest Mid-Day Gainers For Thursday,2017-03-02 12:39:00-05:00,AUPH,neutral
112178.0,Mid-Day Market Update: Navigator Holdings Gains Following Q4 Results; Endeavour Silver Shares Slide,2017-03-02 12:21:00-05:00,AUPH,positive
112179.0,Mid-Morning Market Update: Markets Edge Lower; Abercrombie & Fitch Earnings Miss Views,2017-03-02 10:00:00-05:00,AUPH,negative
112180.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-03-02 08:14:00-05:00,AUPH,neutral
112181.0,Aurinia Pharma Shares Resume Trading Up 42% at $5.28,2017-03-01 16:37:00-05:00,AUPH,positive
112182.0,Aurinia Pharma Shares to Resume Trade at 4:35 p.m. EST,2017-03-01 16:10:00-05:00,AUPH,positive
112183.0,Aurinia Reports Voclosporin Met 48-Week Remission Endpoints,2017-03-01 16:08:00-05:00,AUPH,neutral
112184.0,Aurinia Pharma Shares Halted News Pending,2017-03-01 16:01:00-05:00,AUPH,positive
112185.0,"Leerink Partners Global Healthcare Conference Concludes Today; Presenters Include Aurinia Pharmaceuticals, Karyopharm Therapeutics, Selecta Biosciences, TESARO, EXACT Sciences, Axovant Sciences, Achaogen",2017-02-16 08:20:00-05:00,AUPH,neutral
112186.0,Aurinia Reports Data Supports Continued Development of Voclosporin in Japanese Patient Population,2017-02-14 07:09:00-05:00,AUPH,positive
112187.0,Key Presenters At Leerink's Healthcare Conference,2017-02-13 15:52:00-05:00,AUPH,neutral
112188.0,"Canaccord Genuity Rare Disease Biopharma One-On-One Day Takes Place Today; Presenters Include Aurinia Pharmaceuticals, Akari Therapeutics, Karyopharm, Selecta Biosciences, Aptose Biosciences, And Gemphire Therapeutics",2017-02-07 08:40:00-05:00,AUPH,neutral
112189.0,Aurinia Names Co. Founder Dr. Richard Glickman CEO,2017-02-06 17:16:00-05:00,AUPH,neutral
112190.0,Here's Your Sell-Side Conference Preview,2017-02-06 15:42:00-05:00,AUPH,neutral
112191.0,25 Stocks Moving In Monday's Pre-Market Session,2017-01-30 08:28:00-05:00,AUPH,neutral
112192.0,Aurinia +16.39% Premarket @$3.55; Co Announced Worldwide Clinical Trials as its CRO for Phase 3 Lupus Nephritis Trial,2017-01-27 08:28:00-05:00,AUPH,neutral
112193.0,13D Filing Shows Growth Equity Opportunities Reporting 11.4% Stake In Aurinia Pharmaceuticals,2017-01-09 11:12:00-05:00,AUPH,positive
112194.0,5 Biggest Price Target Changes For Friday,2016-12-30 08:56:00-05:00,AUPH,neutral
112195.0,18 Stocks Moving In Friday's Pre-Market Session,2016-12-30 08:16:00-05:00,AUPH,neutral
112196.0,12 Biggest Mid-Day Losers For Thursday,2016-12-22 12:59:00-05:00,AUPH,negative
112197.0,Mid-Day Market Update: Micron Climbs On Earnings Beat; OvaScience Shares Slide,2016-12-22 12:22:00-05:00,AUPH,positive
112198.0,Mid-Morning Market Update: Markets Edge Lower; Conagra Earnings Top Views,2016-12-22 10:08:00-05:00,AUPH,negative
112199.0,18 Stocks Moving In Thursday's Pre-Market Session,2016-12-22 08:31:00-05:00,AUPH,neutral
112200.0,Aurina Pharma Sells 11.11M Shares and 1/2 Warrents for $2.25/Share to Underwriters,2016-12-22 06:03:00-05:00,AUPH,positive
112201.0,18 Stocks Moving In Tuesday's Pre-Market Session,2016-12-20 08:32:00-05:00,AUPH,neutral
112202.0,Aurinia Pharma Reports Long-Term Manufacturing Collaboration Deal with Lonza for Voclosporin,2016-12-19 16:09:00-05:00,AUPH,neutral
112203.0,20 Stocks Moving In Wednesday's Pre-Market Session,2016-12-14 08:36:00-05:00,AUPH,neutral
112204.0,20 Stocks Moving In Tuesday's Pre-Market Session,2016-12-13 08:30:00-05:00,AUPH,neutral
112205.0,"Aurinia Confirms Receipt of FDA End of Phase 2 Meeting Minutes, Thinks Will Lead to NDA Submission",2016-12-13 08:04:00-05:00,AUPH,neutral
112206.0,Aurinia Highlights Renal Function Data from Global Phase IIb AURA Study of Voclosporin for Lupus Nephritis at American Society of Nephrology Kidney Week 2016,2016-11-21 09:37:00-05:00,AUPH,neutral
112207.0,Aurinia Pharma Spikes to High of $3.75 on Volume,2016-11-18 10:09:00-05:00,AUPH,neutral
112208.0,Aurinia Pharma Spikes to High of $4.90 on Volume,2016-11-16 10:20:00-05:00,AUPH,neutral
112209.0,Aurinia's Path Forward,2016-11-15 15:06:00-05:00,AUPH,neutral
112210.0,Aurinia Pharma Spikes to High of $3.71 on Volume,2016-11-15 10:01:00-05:00,AUPH,neutral
112211.0,18 Stocks Moving In Thursday's Pre-Market Session,2016-11-03 08:38:00-04:00,AUPH,neutral
112212.0,Aurinia Pharmaceuticals Resumes Trading at $3.15,2016-11-02 17:15:00-04:00,AUPH,neutral
112213.0,Aurinia Says Trial is Expected to Begin in Q2'17,2016-11-02 17:12:00-04:00,AUPH,neutral
112214.0,"Aurinia Reports Plans for Single Phase III Trial of Voclosporin for Treatment of Lupus; 23.7mg BID to Advance Into Double-Blind Placebo Controlled Phase III Study, AURORA Phase III Design Consistent with AURA",2016-11-02 17:11:00-04:00,AUPH,neutral
112215.0,Aurinia Pharmaceuticals to Resume Trading at 5:15 PM ET,2016-11-02 16:55:00-04:00,AUPH,neutral
112216.0,Aurinia Announces Plans For Single Phase III Clinical Trial for Voclosporin in Treatment of Lupus Nephritis Following Successful Completion Of End Of Phase II Meeting With FDA,2016-11-02 16:44:00-04:00,AUPH,positive
112217.0,Aurinia Announces Successful Completion Of End Of Phase II Mtg With FDA,2016-11-02 16:43:00-04:00,AUPH,positive
112218.0,Aurinia Pharma Merits Speculative Buy On M&A Appeal; Phase 3 Study Remains Paramount,2016-11-02 12:05:00-04:00,AUPH,positive
112219.0,"Mackie Research Initiates Coverage On Aurinia Pharmaceuticals Inc - Common Shares at Speculative Buy, Announces $8.00",2016-11-01 19:49:00-04:00,AUPH,positive
112220.0,Aurinia Pharmaceuticals Spikes to High on Volume,2016-10-28 12:01:00-04:00,AUPH,neutral
112221.0,Aurinia Pharma Shares Pop to High of $4.50 on Volume,2016-10-17 14:47:00-04:00,AUPH,positive
112222.0,16 Stocks Moving In Monday's Pre-Market Session,2016-10-10 08:42:00-04:00,AUPH,neutral
112223.0,18 Biggest Mid-Day Losers For Friday,2016-10-07 13:16:00-04:00,AUPH,negative
112224.0,18 Stocks Moving In Friday's Pre-Market Session,2016-10-07 08:29:00-04:00,AUPH,neutral
112225.0,Mid-Afternoon Market Update: Crude Oil Up 1.5%; Alnylam Pharma Shares Tumble On Revusiran Termination,2016-10-06 14:55:00-04:00,AUPH,negative
112226.0,Technical Alert: Clinical Study Boosts Aurinia Pharmaceuticals,2016-10-06 13:45:00-04:00,AUPH,positive
112227.0,12 Biggest Mid-Day Gainers For Thursday,2016-10-06 12:55:00-04:00,AUPH,neutral
112228.0,Mid-Day Market Update: Aurinia Pharmaceuticals Gains On AURION Data; Twitter Shares Slide,2016-10-06 12:22:00-04:00,AUPH,positive
112229.0,Here's Why Aurinia Pharmaceuticals Soared 35% Today,2016-10-06 10:31:00-04:00,AUPH,neutral
112230.0,Stocks Hitting 52-Week Highs,2016-10-06 10:15:00-04:00,AUPH,neutral
112231.0,Mid-Morning Market Update: Markets Open Lower; Yum! Brands Sales Miss Estimates,2016-10-06 09:57:00-04:00,AUPH,negative
112232.0,Shares Of Aurinia Pharmaceuticals Trading Up 32.5% On AURION Data,2016-10-06 09:41:00-04:00,AUPH,positive
112233.0,18 Stocks Moving In Thursday's Pre-Market Session,2016-10-06 08:43:00-04:00,AUPH,neutral
112234.0,18 Stocks Moving In Monday's Pre-Market Session,2016-10-03 08:30:00-04:00,AUPH,neutral
112235.0,"Must Watch Stocks for October 3, 2016",2016-10-03 04:02:00-04:00,AUPH,neutral
112236.0,Friday's After-Hours Movers: A Slow Day Sees Some Stocks Oscillating,2016-10-01 10:51:00-04:00,AUPH,neutral
112237.0,15 Biggest Mid-Day Gainers For Friday,2016-09-30 12:40:00-04:00,AUPH,neutral
112238.0,Mid-Day Market Update: Dow Surges Over 150 Points; Threshold Pharmaceuticals Shares Slide,2016-09-30 12:14:00-04:00,AUPH,positive
112239.0,Mid-Morning Market Update: Markets Open Higher; McCormick Profit Tops Estimates,2016-09-30 10:18:00-04:00,AUPH,positive
112240.0,16 Stocks Moving In Friday's Pre-Market Session,2016-09-30 08:33:00-04:00,AUPH,neutral
112241.0,UPDATE: Aurinia Says 'Comprehensive mortality review concludes that deaths in the AURA-LV study appear to be unrelated to study drug and consistent with complications of LN',2016-09-29 16:55:00-04:00,AUPH,positive
112242.0,"Aurinia Reports Voclosporin Achieved Primary, All Pre-Specific Secondary Endpoints in Phase IIb AURA-LV Study for LN",2016-09-29 16:54:00-04:00,AUPH,neutral
112243.0,Aurinia Pharma Shares Halted News Pending,2016-09-29 16:33:00-04:00,AUPH,positive
112244.0,18 Biggest Mid-Day Gainers For Wednesday,2016-08-17 12:54:00-04:00,AUPH,neutral
112245.0,Aurina Pharmaceuticals +21% Premarket @ $2.80; HC Wainwright Raises PT to $10,2016-08-17 08:39:00-04:00,AUPH,neutral
112246.0,20 Stocks Moving In Wednesday's Pre-Market Session,2016-08-17 08:18:00-04:00,AUPH,neutral
112247.0,12 Biggest Mid-Day Gainers For Tuesday,2016-08-16 12:38:00-04:00,AUPH,neutral
112248.0,Mid-Afternoon Market Update: Crude Oil Up 2.7%; Providence & Worcester Railroad Shares Spike Higher,2016-08-15 14:57:00-04:00,AUPH,negative
112249.0,10 Biggest Mid-Day Losers For Monday,2016-08-15 13:15:00-04:00,AUPH,negative
112250.0,Mid-Day Market Update: Sorl Auto Parts Gains Following Q2 Results; Performance Sports Shares Slide,2016-08-15 12:16:00-04:00,AUPH,positive
112251.0,Mid-Morning Market Update: Markets Open Higher; SYSCO Profit Tops Estimates,2016-08-15 10:10:00-04:00,AUPH,positive
112252.0,12 Stocks Moving In Monday's Pre-Market Session,2016-08-15 08:25:00-04:00,AUPH,neutral
112253.0,Aurinia Pharma Phase IIB Voclosporin Study Meets Primary Endpoint,2016-08-15 06:08:00-04:00,AUPH,neutral
112254.0,H.C. Wainwright Initiates Coverage on Aurinia Pharmaceuticals at Buy,2016-06-30 09:38:00-04:00,AUPH,neutral
112255.0,Mid-Afternoon Market Update: Fed Leaves Rates Unchanged; Bob Evans Farms Shares Drop Following Weak Forecast,2016-06-15 14:37:00-04:00,AUPH,negative
112256.0,7 Biggest Mid-Day Losers For Wednesday,2016-06-15 13:17:00-04:00,AUPH,negative
112257.0,Mid-Day Market Update: Patriot National Climbs Following Offer from Ebix; Carbylan Therapeutics Shares Tumble,2016-06-15 12:14:00-04:00,AUPH,positive
112258.0,Mid-Morning Market Update: Markets Open Higher; Aegerion Pharmaceuticals And QLT Agree To Merge,2016-06-15 09:55:00-04:00,AUPH,positive
112259.0,Aurinia Reports Private Placement of Shares at $2.36/Unit for Total $7.08M,2016-06-15 07:07:00-04:00,AUPH,positive
112260.0,Aurinia Reports Q1 EPS $(0.13) vs Est. $(0.14),2016-05-11 17:31:00-04:00,AUPH,neutral
112261.0,Aurinia Initiates First Clinical Study of Voclosporin for Japan,2016-05-09 07:22:00-04:00,AUPH,neutral
112262.0,Aurinia Names Charles Rowland CEO,2016-04-11 07:35:00-04:00,AUPH,neutral
112263.0,Aurinia Announces Safety Monitoring Board Recommends Phase 2 Trial Continues as Scheduled,2016-03-29 06:47:00-04:00,AUPH,positive
112264.0,Aurina Reports Received FDA Fast Track Designation for Voclosporin for Treatment of Lupus Nephritis,2016-03-02 09:00:00-05:00,AUPH,neutral
112265.0,Aurinia Pharma Reports 100% Of Patients Receiving Voclosporin Therapy Achieved At Least 25% Reduction of Proteinuria With Mean Decrease Of 72%,2016-02-08 08:34:00-05:00,AUPH,neutral
112266.0,"Aurinia Reports Completion Of Phase 2B Aura-LV Study In Lupus Nephritis, Primary End-Point Analysis Expected In ~28 Weeks",2016-01-19 17:19:00-05:00,AUPH,neutral
112267.0,Aurinia Pharma Reports Completion of Patient Enrollment in Phase 2B AURA-LV Trial in Lupus Nephritis,2016-01-19 17:17:00-05:00,AUPH,neutral
112268.0,Aurinia Pharmaceuticals Announces Outcome from Data and Safety Monitoring Board for Its Phase 2b Study in Lupus Nephritis – Study to Continue as Planned,2015-11-24 08:30:00-05:00,AUPH,positive
112269.0,Aurinia Reports Q3 EPS ($0.16) vs. Est. ($0.23),2015-11-13 16:18:00-05:00,AUPH,neutral
112270.0,Gilead's Sofosbuvir Just Made Achillion Investors Very Happy,2015-02-09 22:01:00-05:00,AUPH,positive
112271.0,"Leerink Swann Initiates Coverage on Aurinia Pharmaceuticals at Outperform, Announces $8.00 PT",2015-02-02 09:08:00-05:00,AUPH,neutral
